FDA Issues Warnings Regarding Xeljanz (tofacitinib)
On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of
Learn MoreXeljanz
On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of
Learn More